49 related articles for article (PubMed ID: 23103072)
1. Favorable clinical outcomes of pemetrexed treatment in anaplastic lymphoma kinase positive non-small-cell lung cancer.
Lee HY; Ahn HK; Jeong JY; Kwon MJ; Han JH; Sun JM; Ahn JS; Park K; Choi YL; Ahn MJ
Lung Cancer; 2013 Jan; 79(1):40-5. PubMed ID: 23103072
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes of patients with resected, early-stage ALK-positive lung cancer.
Chaft JE; Dagogo-Jack I; Santini FC; Eng J; Yeap BY; Izar B; Chin E; Jones DR; Kris MG; Shaw AT; Gainor JF
Lung Cancer; 2018 Aug; 122():67-71. PubMed ID: 30032847
[TBL] [Abstract][Full Text] [Related]
3. Real-world first-line treatment and overall survival in non-small cell lung cancer without known EGFR mutations or ALK rearrangements in US community oncology setting.
Abernethy AP; Arunachalam A; Burke T; McKay C; Cao X; Sorg R; Carbone DP
PLoS One; 2017; 12(6):e0178420. PubMed ID: 28644837
[TBL] [Abstract][Full Text] [Related]
4. Exploratory analysis of the association of depth of response and survival in patients with metastatic non-small-cell lung cancer treated with a targeted therapy or immunotherapy.
McCoach CE; Blumenthal GM; Zhang L; Myers A; Tang S; Sridhara R; Keegan P; Pazdur R; Doebele RC; Kazandjian D
Ann Oncol; 2017 Nov; 28(11):2707-2714. PubMed ID: 29045514
[TBL] [Abstract][Full Text] [Related]
5. RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK-positive lung cancer.
Hrustanovic G; Olivas V; Pazarentzos E; Tulpule A; Asthana S; Blakely CM; Okimoto RA; Lin L; Neel DS; Sabnis A; Flanagan J; Chan E; Varella-Garcia M; Aisner DL; Vaishnavi A; Ou SH; Collisson EA; Ichihara E; Mack PC; Lovly CM; Karachaliou N; Rosell R; Riess JW; Doebele RC; Bivona TG
Nat Med; 2015 Sep; 21(9):1038-47. PubMed ID: 26301689
[TBL] [Abstract][Full Text] [Related]
6. The value of innovation: association between improvements in survival of advanced and metastatic non-small cell lung cancer and targeted and immunotherapy.
Ramagopalan S; Leahy TP; Ray J; Wilkinson S; Sammon C; Subbiah V
BMC Med; 2021 Sep; 19(1):209. PubMed ID: 34521405
[TBL] [Abstract][Full Text] [Related]
7. Lung cancer patients with anaplastic lymphoma kinase rearrangement lose affiliation with labor market at diagnosis.
Andersen JL; Johansen JS; Urbanska EM; Meldgaard P; Hjorth-Hansen P; Kristiansen C; Stelmach M; Santoni-Rugiu E; Ulhøi MP; Højgaard B; Jensen MS; Dydensborg AB; Dünweber C; Hansen KH
Lung Cancer Manag; 2024; 13(1):LMT68. PubMed ID: 38818369
[TBL] [Abstract][Full Text] [Related]
8. HIV-associated Non-small-cell Lung Cancer with Rearrangement of the Anaplastic Lymphoma Kinase Gene: A Report of Two Patients.
Pichardo R; Go RF; Qu L; Hussein L; Gupta S
Cureus; 2019 Aug; 11(8):e5466. PubMed ID: 31523585
[TBL] [Abstract][Full Text] [Related]
9. The Impact of Kinlessness on Survival in Patients With Advanced Non-small Cell Lung Cancer: A Single-Center Retrospective Study.
Omura A; Nojiri T; Higashiyama M
Cureus; 2024 Apr; 16(4):e57820. PubMed ID: 38721224
[TBL] [Abstract][Full Text] [Related]
10. Salvage pemetrexed for brain metastases from ALK-positive lung cancer after Gamma Knife radiosurgery: illustrative case.
Noda R; Akabane A; Kawashima M; Segawa M; Tsunoda S; Inoue T
J Neurosurg Case Lessons; 2024 Mar; 7(11):. PubMed ID: 38467041
[TBL] [Abstract][Full Text] [Related]
11. Histo-Molecular Factors of Response to Combined Chemotherapy and Immunotherapy in Non-Small Cell Lung Cancers.
Marchal M; Leroy V; Behal H; Dansin E; Paris N; Bordier S; Humez S; Escande F; Gauvain C; Cortot AB
Target Oncol; 2023 Nov; 18(6):927-939. PubMed ID: 37921939
[TBL] [Abstract][Full Text] [Related]
12. Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer with Brain Metastasis : The Role of Gamma Knife Radiosurgery.
Lee MH; Cho KR; Choi JW; Kong DS; Seol HJ; Nam DH; Jung HA; Sun JM; Lee SH; Ahn JS; Ahn MJ; Park K; Lee JI
J Korean Neurosurg Soc; 2021 Mar; 64(2):271-281. PubMed ID: 33267531
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of resistance to pemetrexed in non-small cell lung cancer.
Liang J; Lu T; Chen Z; Zhan C; Wang Q
Transl Lung Cancer Res; 2019 Dec; 8(6):1107-1118. PubMed ID: 32010588
[TBL] [Abstract][Full Text] [Related]
14. Primary signet-ring adenocarcinoma of the lung: A rare lung tumor.
Rajpal V; Sharma RK; Dabral C; Talwar D
South Asian J Cancer; 2019; 8(4):257. PubMed ID: 31807493
[No Abstract] [Full Text] [Related]
15. Afatinib Overcomes Pemetrexed-Acquired Resistance in Non-Small Cell Lung Cancer Cells Harboring an EML4-ALK Rearrangement.
Kwon JH; Kim KJ; Sung JH; Suh KJ; Lee JY; Kim JW; Kim SH; Lee JO; Kim JW; Kim YJ; Lee KW; Kim JH; Bang SM; Kim S; Yoon SS; Lee JS
Cells; 2019 Nov; 8(12):. PubMed ID: 31795298
[TBL] [Abstract][Full Text] [Related]
16. Lung cancer family history and exposure to occupational/domestic coal combustion contribute to variations in clinicopathologic features and gene fusion patterns in non-small cell lung cancer.
Chen Y; Li G; Lei Y; Yang K; Niu H; Zhao J; He R; Ning H; Huang Q; Zhou Q; Huang Y
Thorac Cancer; 2019 Apr; 10(4):695-707. PubMed ID: 30775858
[TBL] [Abstract][Full Text] [Related]
17. Autochthonous murine models for the study of smoker and never-smoker associated lung cancers.
Akbay EA; Kim J
Transl Lung Cancer Res; 2018 Aug; 7(4):464-486. PubMed ID: 30225211
[TBL] [Abstract][Full Text] [Related]
18. [Association between the ALK Gene Status and the Efficacy of First-line
Pemetrexed Chemotherapy in Patients with Advanced Lung Adenocarcinoma].
Chen M; Cao H; Ji Y; Mao Y; Shen S; Li X
Zhongguo Fei Ai Za Zhi; 2017 Nov; 20(11):732-736. PubMed ID: 29167001
[TBL] [Abstract][Full Text] [Related]
19. The Influence of Biomarker Mutations and Systemic Treatment on Cerebral Metastases from NSCLC Treated with Radiosurgery.
Lee MH; Kong DS; Seol HJ; Nam DH; Lee JI
J Korean Neurosurg Soc; 2017 Jan; 60(1):21-29. PubMed ID: 28061489
[TBL] [Abstract][Full Text] [Related]
20. Clinical effect of pemetrexed as the first-line treatment in Chinese patients with advanced anaplastic lymphoma kinase-positive non-small cell lung cancer.
Ma D; Hao X; Wang Y; Xing P; Li J
Thorac Cancer; 2016 Jul; 7(4):452-8. PubMed ID: 27385988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
